Start-Up Spotlight: LimFlow, Endovascular Treatment For End-Stage Critical Limb Ischemia

17 Aug 2017

French start-up LimFlow is developing a percutaneous deep vein arterialization system, designed for installing a stent-graft that shunts blood from a diseased tibial artery into a tibial vein to revascularize the foot of a patient with severe peripheral artery disease.

LimFlow SA expects the US pivotal trial of the LimFlow percutaneous deep vein arterialization (PDVA) system for treating end-stage critical limb ischemia to begin in 2018, building on the encouraging results from a pilot trial.

The company was founded in 2012 in France to develop a percutaneous system for deep vein arterialization of the foot...